Skip to content

Analysis of the anesthetic effects of alfentanil combined with ciprofol for gynecological outpatient short operation

Analysis of the anesthetic effects of alfentanil combined with ciprofol for gynecological outpatient short operation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102903
Enrollment
Unknown
Registered
2025-05-21
Start date
2025-06-20
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial abortion, Diagnostic curettage

Interventions

CA1 group:Ciprofol + alfentanil 5µg/kg
CA2 group:Ciprofol + alfentanil 7µg/kg
C group:Ciprofol + NS

Sponsors

The First Affiliated Hospital of Jinan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Patients who required elective artificial abortion/curettage/diagnostic curettage under intravenous general anesthesia in Day surgery Center of the First Affiliated Hospital of Jinan University were selected. 2) Age: 18-60 years old 3) BMI: 18.5-28 kg/m2 4) ASA grade: I-II

Exclusion criteria

Exclusion criteria: 1) Co-existing with mental or psychological diseases or using corresponding drugs; 2) Patients with a history of abnormal anesthesia recovery; 3) History of severe heart, liver, lung, kidney, or brain diseases; 4) Patients with obstructive sleep apnea syndrome, predicted to have or had a difficult airway; 5) Allergic to known emulsions or opioids; 6) Patients during lactation; 7) History of chronic pain; 8) Those who do not cooperate and cannot communicate.

Design outcomes

Primary

MeasureTime frame
Satisfaction of gynecologists with the effect of anesthesia;

Secondary

MeasureTime frame
Injection pain;Coughing/Body movement/Moaning/Muscle twitching;Hypoxia;Satisfaction of patient with the effect of anesthesia;Satisfaction of anesthesiologist with the effect of anesthesia;Awakening time;Recovery time of orientation;The total amount of ciprofol;

Countries

China

Contacts

Public ContactMengxia Wang

The First Affiliated Hospital of Jinan University

wmx_strive@163.com+86 156 2646 7868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026